Related Experiment Videos
Feminizing Leydig cell tumor: endocrine and incubation studies
Journal of Endocrinological Investigation
|April 1, 1987
Summary
A Leydig cell tumor caused gynecomastia by producing excess estrogen. Surgical removal of the tumor normalized hormone levels and resolved gynecomastia, highlighting the tumor
Area of Science:
- Endocrinology
- Oncology
- Reproductive Medicine
Background:
- Gynecomastia can be associated with testicular tumors.
- Leydig cell tumors are rare and can cause hormonal imbalances.
Observation:
- A 32-year-old male presented with gynecomastia and was diagnosed with a left testicular Leydig cell tumor.
- Preoperative hormone levels showed elevated estradiol (E2) and estrone (E1), with suppressed luteinizing hormone (LH), follicle-stimulating hormone (FSH), and testosterone (T).
Findings:
- hCG stimulation revealed an exaggerated and prolonged E2 response, while testosterone normalized temporarily.
- Post-orchiectomy, gynecomastia resolved rapidly, and hormone levels (gonadotropins, estrogens, testosterone, 5α-dihydrotestosterone) normalized within weeks.
- Tumor tissue exhibited significantly higher aromatase activity and Leydig cell volume compared to normal tissue, suggesting tumor-driven estrogen production.
Implications:
- Leydig cell tumors can cause significant hormonal disturbances, including estrogen excess leading to gynecomastia.
- Tumor aromatase activity is a key factor in the pathophysiology of hormone-related symptoms.
- Juxtatumoral Leydig cell hyperplasia suggests a potential growth-stimulating factor produced by the tumor.